Levocarnitine
11 NDCs across 4 manufacturers|6 Generic,5 Brand
Levocarnitine is used to treat deficiency diseases, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 27, 1985, and the first generic was approved Mar 29, 2001. FDA's Orange Book lists 3 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $4 million on Levocarnitine across 39,000 claims for 5,860 beneficiaries.
Levocarnitine is available as 11 NDCs from 4 manufacturers (6 generic, 5 brand), with NADAC prices from $0.15 to $0.54 per ML — the most expensive product costs about 3.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
11
6G / 5B
Manufacturers
4
competing in market
Price Spread
$0.15 – $0.54
per ML, 8 of 11 NDCs
7d Activity
avg +2.7% WoW · of 11 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Leadiant Biosciences, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Carnitine Analog class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing LEVOCARNITINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CARNITOR 330 MG TABLET | $1.2272 per EA | — |
LEVOCARNITINE 330 MG TABLET | $0.6706 per EA | +1.43% |
LEVOCARNITINE 330 MG TABLET | $0.6706 per EA | +1.43% |
CARNITOR SF 1 GM/10 ML SOLN | $0.5357 per ML | — |
CARNITOR SF 1 GM/10 ML SOLN | $0.5357 per ML | — |
CARNITOR 1 GM/10 ML ORAL SOLN | $0.4416 per ML | — |
CARNITOR 100 MG/ML ORAL SOLN | $0.3397 per ML | — |
LEVOCARNITINE SF 1 G/10 ML SOL | $0.2522 per ML | -0.61% |
LEVOCARNITINE 1 G/10 ML SOLN | $0.1450 per ML | +4.58% |
LEVOCARNITINE 1 G/10 ML SOLN | $0.1450 per ML | +4.58% |
LEVOCARNITINE 1 G/10 ML SOLN | $0.1450 per ML | +4.58% |
Frequently Asked Questions
What is Levocarnitine used to treat?
Levocarnitine is used to treat deficiency diseases, per the National Library of Medicine's MED-RT classification.
When did Levocarnitine become available as a generic?
FDA approved the first generic Levocarnitine (ANDA) on Mar 29, 2001. The Orange Book currently lists 3 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Levocarnitine?
In 2024, Medicare Part D spent $4 million on Levocarnitine across 39,000 claims for 5,860 beneficiaries.
How many Levocarnitine products are on the market?
The Levocarnitine drug market contains 11 NDCs from 4 manufacturers — 6 generic and 5 brand products.
What is the price range for Levocarnitine?
NADAC reference prices for Levocarnitine range from $0.1450 to $0.5357 per ML — the most expensive product costs about 3.7× the cheapest. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Levocarnitine cheaper than brand?
The average generic NADAC for Levocarnitine is $0.1718 per ML, versus $0.4632 for brand-labeled products — brand versions average about 2.7× the generic price.
Which manufacturers make Levocarnitine?
4 manufacturers list Levocarnitine in NADAC. Ranked by number of NDCs, the largest are Leadiant Biosciences, Inc. (5), ANI Pharmaceuticals, Inc. (3), Rising Pharma Holdings Inc. (2), TruPharma LLC (1).
How has the price of Levocarnitine changed recently?
Over the past 7 days, 5 Levocarnitine NDCs rose and 1 fell, with a market-wide average change of +2.7%.